Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
41.8 EUR | -0.48% | -7.52% | -3.69% |
23/04 | Xlife Sciences Posts Higher FY23 Profit; Revenue Falls | MT |
29/02 | Xlife Sciences AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Performance
1 day | -0.48% | ||
Current month | -3.69% | ||
Current year | -3.69% | ||
3 years | -13.99% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Biotechnology & Medical Research
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-0.48% | -7.52% | -3.69% | - | 214M | ||
+0.11% | +1.47% | +1.46% | +23.55% | 42.75B | ||
-1.02% | +3.08% | +47.70% | -5.60% | 41.61B | ||
+3.76% | +6.72% | +12.10% | -16.43% | 41.34B | ||
+4.02% | +6.25% | -8.83% | +14.38% | 26.59B | ||
-1.56% | +1.63% | +6.96% | +54.91% | 25.49B | ||
+2.74% | +1.05% | -23.03% | -27.02% | 18.12B | ||
+0.64% | +5.87% | +29.96% | +92.92% | 12.24B | ||
+0.87% | -0.70% | -2.31% | +21.48% | 11.76B | ||
+1.80% | +1.81% | +8.37% | +2.67% | 11B | ||
+0.58% | +2.56% | -16.52% | -18.71% | 10.07B | ||
+8.42% | +2.29% | -5.83% | -8.62% | 9.22B | ||
+0.12% | +3.57% | +24.92% | -15.11% | 6.65B | ||
+3.41% | +20.21% | +8.55% | -34.40% | 6.44B | ||
+3.45% | +1.87% | +29.39% | +55.60% | 6.13B | ||
-.--% | -.--% | - | - | 6.07B | ||
Average | +1.15% | +3.62% | +7.28% | +9.97% | ||
Weighted average by Cap. | +1.08% | +3.94% | +9.95% | +9.49% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2022 | -2.69% | ||
2021 | -10.80% | ||
2020 | +66.67% | ||
2019 | -.--% |
- Stock Market
- Equities
- XLS Stock
- XLS Stock
- Quotes Xlife Sciences AG